AdvanSix Inc. ASIX

MaterialsChemicalsUnited States of America

Last close 15.53 USD on Nov 2, 2026, −7.9% year to date

Quant rating

Quant rating C Rank 104 of 151 in Materials

Growth A 20 of 151
Valuation B 60 of 151
Quality C 85 of 151
Revisions D 122 of 151
Momentum D 128 of 151

Wall Street consensus Buy (2.50)Average target 20.00 USD +28.8%

Historical valuation

Multiples use consensus estimates for the next twelve months. The dashed line is the 5-year average.

Key data

Market cap: 419M
Enterprise value: 687M
52-week range: 14.10 – 26.71
3-year range: 14.10 – 32.87
Dividend yield: 4.17%
Beta (5 years): 1.26
Shares outstanding: 27.0M
Next earnings: Nov 4, 2026

About the company

AdvanSix Inc. is a vertically integrated chemistry company that produces essential materials for diverse end markets across building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives, electronics and other end markets. Its product lines include nylon solutions, plant nutrients, and chemical intermediates. It sells its Nylon 6 resin, under the Aegis brand name. It also markets and sells Caprolactam to manufacture polymer resins to produce fibers, compounds and other nylon products. It markets and sells ammonium sulfate to North American and South American distributors, farm cooperatives and retailers to fertilize crops. It manufactures sulfuric acid, ammonia and carbon dioxide. Its other intermediate chemicals include phenol, alpha-methyl styrene, cyclohexanone, oximes, cyclohexanol, and alkyl and specialty amines. Its end-products for intermediates include automotive components and water treatment and pharmaceutical intermediates.

Growth and profitability fiscal year ends December 31

Growth and profitability by fiscal year
	2025	2024	2023	2022	2021	5Y avg
Revenue (mil)	1,522	1,518	1,534	1,946	1,685	–
Revenue growth	0.3%	−1.0%	−21.2%	15.5%	45.5%	5.6%
EPS (basic, normalized)	2.28	1.96	2.14	5.92	4.81	–
EPS growth	16.3%	−8.4%	−63.9%	23.1%	–	–
Gross margin	10.8%	10.1%	10.8%	16.2%	16.3%	12.8%
Net margin	3.2%	2.9%	3.6%	8.8%	8.3%	5.4%
ROE	6.2%	5.8%	7.4%	25.7%	26.7%	14.4%

Balance sheet, last quarter
Cash & short-term investments (mil)	7.2
Current ratio	1.28x
Long-term debt (mil)	275
Net debt (mil)	268
Total equity (mil)	797
Net debt / equity	0.34x
Net debt / EBITDA	1.71x

Estimates and valuation

Consensus estimates and implied multiples
	Sales (mil)			EBITDA (mil)			EPS
Fiscal year	Mean est.	Growth	EV/Sales	Mean est.	Growth	EV/EBITDA	Mean est.	Growth	P/E
2025 actual	1,522	+0.3%	0.5x	157	+13.1%	4.4x	2.28	+16.3%	6.8x
2026	1,672	+9.9%	0.4x	98.5	−37.2%	7.0x	0.18	−91.9%	83.9x
2027	1,757	+5.1%	0.4x	165	+67.8%	4.2x	2.38	+1,189.2%	6.5x

Estimate revisions

Change in consensus estimates over 1, 3 and 6 months
	Sales				EPS
Fiscal year	Estimate (mil)	1M	3M	6M	Estimate	1M	3M	6M
2026	1,672	0.0%	−0.9%	+7.6%	0.18	0.0%	−87.1%	−87.9%
2027	1,757	0.0%	−1.0%	+8.0%	2.38	0.0%	−18.5%	−16.0%
2028	–	–	–	–	–	–	–	–

Earnings surprises

Reported results versus consensus, last 10 fiscal quarters
Quarter ended	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales reported (mil)	337	453	398	329	378	410	374	360	404	421
Sales mean (mil)	345	427	368	374	347	–	365	341	365	452
Surprise	−2.3%	+6.3%	+8.3%	−12.0%	+8.8%	–	+2.6%	+5.6%	+10.8%	−6.8%
EPS reported	−0.56	1.55	0.88	0.09	0.93	1.24	0.08	0.03	−0.50	0.19
EPS mean	−0.54	1.20	0.66	−0.38	0.82	–	0.40	−0.06	−0.47	0.56
Surprise	−3.7%	+29.7%	+34.4%	−124.0%	+12.7%	–	−80.0%	−150.0%	−5.3%	−65.8%

Peer comparison Chemicals

Peers in the same industry group, by market capitalization
Company	Market cap	Net debt/EBITDA	Net margin	P/B	FY1 P/E	FY2 P/E	FY1 EV/EBITDA	FY2 EV/EBITDA
ASIX AdvanSix Inc.	419M	1.71x	3.2%	0.53x	83.9x	6.5x	7.0x	4.2x
NTR Nutrien Ltd	33.5B	2.03x	8.4%	1.30x	14.3x	13.9x	7.2x	7.2x
ESI Element Solutions Inc	8.3B	3.42x	7.5%	2.88x	18.4x	15.8x	14.2x	12.6x
WLK Westlake Corp	9.1B	3.27x	−13.4%	1.04x	37.4x	29.8x	7.4x	7.2x
MX Methanex Corporation	5.3B	3.21x	2.2%	1.89x	6.5x	10.9x	4.1x	5.8x
FUPBY Fuchs Se	5.9B	−0.07x	8.6%	2.65x	15.4x	15.0x	8.7x	8.6x
Mean		2.26x	2.8%	1.71x	29.3x	15.3x	8.1x	7.6x
Median		2.62x	5.4%	1.59x	16.9x	14.4x	7.3x	7.2x

Technical analysis

1M−4.3%
3M−21.8%
1Y−13.3%
3Y−39.6%

Financial statements in millions of USD

Income statement in millions of USD, fiscal years

Income statement, AdvanSix Inc., fiscal years, most recent first
	2025	2024	2023	2022	2021	2020
Total revenue	1,522	1,518	1,534	1,946	1,685	1,158
Cost of revenue	1,357	1,365	1,369	1,631	1,411	1,024
Gross profit	165	153	165	314	274	134
Selling, general & administrative expenses	105	94.0	95.5	87.7	83.0	70.9
Research & development	–	–	–	–	–	–
Interest expense (income), operating	–	–	–	–	–	–
Unusual expense (income)	–	–	–	–	–	–
Other operating expenses	0	0	0	0	0	0
Operating income	60.2	58.9	69.5	227	191	62.9
Net interest income (expense)	−8.5	−11.3	−7.5	−2.8	−5.0	−7.8
Gain (loss) on sale of assets	–	–	–	–	–	–
Other non-operating income (expense)	2.7	−2.0	7.2	1.8	−1.0	−0.1
Net income before taxes	54.4	45.6	69.2	226	185	55.0
Provision for taxes	5.1	1.4	14.6	53.9	45.3	9.0
Minority interest	–	–	–	–	–	–
Equity in affiliates	–	–	–	–	–	–
U.S. GAAP adjustment	–	–	–	–	–	–
Net income before extraordinary items	49.3	44.1	54.6	172	140	46.1
Extraordinary items	–	–	–	–	–	–
Net income	49.3	44.1	54.6	172	140	46.1
EBIT, normalized	67.5	57.7	65.1	227	191	62.9
EBITDA, normalized	147	134	138	296	256	124
Basic EPS, normalized	2.28	1.96	2.14	5.92	4.81	–

Balance sheet in millions of USD, fiscal years

Balance sheet, AdvanSix Inc., fiscal years, most recent first
	2025	2024	2023	2022	2021	2020
Assets
Cash & short-term investments	19.8	19.6	29.8	31.0	15.1	10.6
Receivables	176	146	167	185	179	136
Total inventory	236	212	212	216	150	180
Prepaid expenses	–	–	–	–	–	–
Other current assets	8.6	9.0	11.4	9.2	6.1	7.0
Total current assets	441	387	420	441	350	334
Property, plant & equipment	1,128	1,071	948	926	904	880
Goodwill	56.2	56.2	56.2	56.2	17.6	15.0
Intangibles	40.1	43.1	46.2	49.2	–	–
Long-term investments	–	–	–	–	–	–
Note receivable	–	–	–	–	–	–
Other long-term assets	41.0	37.2	25.4	23.2	40.4	34.9
Total assets	1,706	1,595	1,496	1,495	1,312	1,263
Liabilities
Accounts payable	283	228	258	272	221	190
Payable/accrued	–	–	–	–	–	–
Accrued expenses	90.3	89.8	76.1	86.3	85.8	70.4
Short-term debt	0	0	0	0	0	0
Current portion of long-term debt	0.9	0.9	0.8	0.8	0.6	0.5
Other current liabilities	15.6	38.6	23.7	34.4	2.7	26.4
Total current liabilities	390	357	359	393	310	287
Long-term debt	216	197	171	116	136	275
Minority interest	–	–	–	–	–	–
Other liabilities	285	267	226	248	265	257
Total liabilities	891	820	757	757	711	819
Shareholders' equity
Preferred stock	0	0	0	0	0	0
Common stock	0.3	0.3	0.3	0.3	0.3	0.3
Additional paid-in capital	143	137	138	175	196	185
Retained earnings (accumulated deficit)	663	632	605	568	412	275
Treasury stock	−0.1	−0.1	−0.1	0	0	0
Other equity	9.0	6.0	−4.1	−4.2	−6.5	−16.1
Total equity	815	775	739	738	601	444
Total liabilities & shareholders' equity	1,706	1,595	1,496	1,495	1,312	1,263

Cash flow statement in millions of USD, fiscal years

Cash flow statement, AdvanSix Inc., fiscal years, most recent first
	2025	2024	2023	2022	2021	2020
Operating activities
Net income	49.3	44.1	54.6	172	140	46.1
Depreciation, depletion & amortization	79.7	76.2	73.0	69.4	65.3	60.8
Deferred taxes	7.8	−9.0	−9.3	16.2	4.7	17.6
Non-cash items	7.3	10.4	5.7	12.4	13.7	6.2
Changes in working capital	−21.3	13.6	−6.5	3.7	−4.7	−18.8
Cash from operations	123	135	118	274	219	112
Investing activities
Capital expenditures	−116	−134	−107	−89.4	−56.8	−82.9
Other investing cash flows	−6.2	−9.2	−3.5	−99.8	−10.8	−1.2
Cash from investing	−123	−143	−111	−189	−67.6	−84.1
Financing activities
Financing cash flow items	−0.5	–	0	0	−2.4	−0.4
Cash dividends paid	−17.2	−17.1	−16.7	−15.1	−3.5	–
Issuance (retirement) of debt, net	–	–	–	–	–	–
Other financing cash flows	17.6	14.4	8.8	−53.4	−141	−23.8
Cash from financing	0	−2.7	−7.9	−68.4	−147	−24.2
Foreign exchange effects	–	–	–	–	–	–
Net change in cash	0.2	−10.2	−1.2	15.9	4.5	3.6
Free cash flow	6.4	1.7	10.2	184	162	28.9

Disclaimer

The financial data presented in this report is delayed and obtained from sources QDD Research believes to be reliable, including stock exchanges, SEDAR, and EDGAR. However, no representation or warranty is made as to the accuracy, completeness, or timeliness of the information. QDD Research accepts no liability for any errors, omissions, or financial losses arising from the use of this data.

This report is generated using a fully systematic and quantitative approach. All factor scores and the overall quant rating (ranging from D to A+) are derived from algorithmic models and are based solely on objective financial metrics. These scores are intended for informational purposes only and should not be interpreted as investment advice or a recommendation to buy, sell, or hold any securities.

QDD Research is not a registered investment advisor or broker-dealer and does not provide personalized financial advice. The content is not tailored to the specific investment goals, financial situation, or risk profile of any individual investor. We strongly encourage readers to consult with a licensed broker or investment advisor before making any investment decisions based on the information contained in this report.

Live quote provided by TradingView. Report data updated Nov 2, 2026 after market close.